Jurui Luo

610 total citations
21 papers, 417 citations indexed

About

Jurui Luo is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jurui Luo has authored 21 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 11 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Jurui Luo's work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (7 papers) and Breast Implant and Reconstruction (5 papers). Jurui Luo is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (7 papers) and Breast Implant and Reconstruction (5 papers). Jurui Luo collaborates with scholars based in China and United States. Jurui Luo's co-authors include Xiaomao Guo, Xiaoli Yu, Zhaozhi Yang, Xuanyi Wang, Zhirui Zhou, Jinli Ma, Zhengrong Zhou, Xin Mei, Feng Yan and Zhen Zhang and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Advanced Science and Medicine.

In The Last Decade

Jurui Luo

20 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jurui Luo China 9 162 156 144 117 100 21 417
Itai Pashtan United States 11 164 1.0× 166 1.1× 121 0.8× 87 0.7× 153 1.5× 25 504
Shuiping Gao China 13 229 1.4× 263 1.7× 194 1.3× 74 0.6× 99 1.0× 28 539
Joanna Niemiec Poland 14 243 1.5× 114 0.7× 134 0.9× 124 1.1× 163 1.6× 47 462
Saskia van de Ven Netherlands 8 242 1.5× 63 0.4× 193 1.3× 64 0.5× 58 0.6× 14 361
Maartje van Seijen Netherlands 8 176 1.1× 57 0.4× 163 1.1× 54 0.5× 64 0.6× 14 337
Benjamin D. Li United States 10 134 0.8× 306 2.0× 164 1.1× 66 0.6× 47 0.5× 15 519
Chuanben Chen China 14 235 1.5× 158 1.0× 74 0.5× 53 0.5× 176 1.8× 61 539
Ruifei Xie China 9 186 1.1× 167 1.1× 106 0.7× 126 1.1× 109 1.1× 16 449
Tomoyuki Aruga Japan 13 230 1.4× 71 0.5× 161 1.1× 33 0.3× 132 1.3× 59 403
Henrica M.J. Werner Norway 13 114 0.7× 171 1.1× 120 0.8× 120 1.0× 94 0.9× 21 680

Countries citing papers authored by Jurui Luo

Since Specialization
Citations

This map shows the geographic impact of Jurui Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurui Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurui Luo more than expected).

Fields of papers citing papers by Jurui Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jurui Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurui Luo. The network helps show where Jurui Luo may publish in the future.

Co-authorship network of co-authors of Jurui Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jurui Luo. A scholar is included among the top collaborators of Jurui Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurui Luo. Jurui Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Zhe, Li Zhang, Wei Shi, et al.. (2024). Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple‐Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1‐Regulated Cholesterol Metabolism. Advanced Science. 12(5). e2413103–e2413103. 1 indexed citations
3.
Wang, Xuanyi, Kairui Jin, Jurui Luo, et al.. (2022). Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery. Cancer Medicine. 11(14). 2755–2766. 3 indexed citations
5.
Zhang, Li, Xiaomeng Zhang, Jurui Luo, et al.. (2021). Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?. Breast Cancer Research and Treatment. 190(2). 277–286. 6 indexed citations
6.
Jin, Kairui, Jurui Luo, Xuanyi Wang, et al.. (2021). Symptoms Related to Brachial Plexus Neuropathy After Supraclavicular Irradiation and Boost in Breast Cancer. Practical Radiation Oncology. 12(1). e13–e23. 2 indexed citations
7.
Mo, Miao, Jing Yuan, Jurui Luo, et al.. (2021). Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy. Cancer Management and Research. Volume 13. 3889–3899. 2 indexed citations
8.
Luo, Jurui, et al.. (2021). Does the protocol-required uniform margin around the CTV adequately account for setup inaccuracies in whole breast irradiation?. Radiation Oncology. 16(1). 143–143. 9 indexed citations
9.
Luo, Jurui, Kairui Jin, Xuanyi Wang, et al.. (2020). Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients. Cancer Medicine. 9(7). 2427–2434. 8 indexed citations
10.
Luo, Jurui, Xingxing Chen, Zhaozhi Yang, et al.. (2020). CDK4/6 inhibitors: a novel strategy for tumor radiosensitization. Journal of Experimental & Clinical Cancer Research. 39(1). 188–188. 51 indexed citations
11.
Wang, Xuanyi, Jurui Luo, Kairui Jin, et al.. (2019). Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting. Breast Cancer. 27(2). 252–260. 6 indexed citations
12.
Zhang, Li, Kairui Jin, Xuanyi Wang, et al.. (2019). The Impact of Radiotherapy on Reoperation Rates in Patients Undergoing Mastectomy and Breast Reconstruction. Annals of Surgical Oncology. 26(4). 961–968. 13 indexed citations
13.
Luo, Jurui, et al.. (2019). <p>Single institution experience of split course radiotherapy in patients with desmoid tumors</p>. OncoTargets and Therapy. Volume 12. 1741–1748. 3 indexed citations
14.
Liu, Zhiyi, Li Zhang, Zhaozhi Yang, et al.. (2018). Targeting deubiquitinase USP28 for cancer therapy. Cell Death and Disease. 9(2). 186–186. 80 indexed citations
15.
16.
Luo, Jurui, Kairui Jin, Xingxing Chen, et al.. (2018). Internal Mammary Node Irradiation (IMNI) Improves Survival Outcome for Patients With Clinical Stage II-III Breast Cancer After Preoperative Systemic Therapy. International Journal of Radiation Oncology*Biology*Physics. 103(4). 895–904. 16 indexed citations
17.
Zhou, Zhirui, Zhaozhi Yang, Li Zhang, et al.. (2017). The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy. Acta Pharmacologica Sinica. 38(4). 513–523. 71 indexed citations
18.
Chen, Xingxing, Ningyi Ma, Zhirui Zhou, et al.. (2017). Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells. Medical Science Monitor. 23. 2674–2683. 22 indexed citations
19.
Luo, Jurui. (2016). Prognostic and therapeutic significance of detection of circulating tumor cells in breast cancer. Zhonghua fangshe zhongliuxue zazhi. 25(4). 420–424. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026